(Press-News.org) Emergency departments (EDs) are currently unsafe places for both professionals and patients, according to the results of an international survey carried out for the European Society of Emergency Medicine (EUSEM) and published today (26th May) in the European Journal of Emergency Medicine1. The main reasons for this are staff shortages and overcrowding due to the non-availability of beds in wards necessitating the provision of care in corridors. Respondents to the survey also felt that they had insufficient support from hospital management.
Around 90% of professionals surveyed felt that at times the number of patients in ED exceeded the capacity of the department to provide safe care, and that such overcrowding was a regular problem. In addition to causing patient and professional discomfort and impeding their ability to provide care, overcrowding is known to carry a substantial risk of harm and increased mortality.
The preliminary findings of a survey among patients, yet to be published, were even more alarming. More patients thought that ED staff were ‘angry’ or ‘rude’ than were kind. This is likely to be caused by exhaustion and frustration, says an accompanying editorial2 from EUSEM President Dr James Connolly ‘given that the vast majority of those responding to the survey of professionals said that they were proud to work in an ED.’ Amongst responses received a typical response was “There were a lot of patients and very few doctors. Some nurses were very stressed.”
Indeed, nurses who responded to the survey felt less safe than did doctors, particularly with regards to the environment in which they had to treat patients with mental health problems. Since in general they work with patients for longer periods of time, this is understandable, but nonetheless troubling, say the researchers.
“Last year’s EUSEM survey into burnout among ED professionals was worrying enough,” says Dr Connolly, “showing as it did that younger and less experienced EM professionals were more likely to be affected than older, more experienced staff. It is very disquieting to see this pattern repeated, and completely unacceptable that so little action has been taken to remedy it. If anything, the situation appears to be worse than before.” This is especially important, as In many EDs the majority of professionals are still junior and therefore at greater risk of burnout, and so in greater need of supervision to protect both themselves and their patients.
Although targets have been advantageous in bringing about improvements in the past, the current feedback from ED staff shows that, when systems are under significant strain, they feel pressurised by the imposition of such external targets, and that they believe this could cause patient care to suffer. Some 54.2% said they were permanently under external pressure. Support from hospital management was also perceived to be inadequate; 35% of professional responders responding that hospital managers never supported the introduction of improvements, and 47% thinking that procedures for improving flow in the ED were never effective.
Alarmingly, some patients surveyed felt so concerned about their safety in the ED that they said they would prefer not to go there at all, believing that overcrowding, long waiting times, and exhausted staff would lead to medical errors.
“Dedicated professionals need the right environment and support in which to carry out their work, and patients need to feel reassured that they will get the best treatment. Currently we are far from that being the case. Governments and healthcare authorities must remedy this now, before the situation worsens further when it may become too late to arrest the spiral of decline,” says Dr Connolly.
Are Emergency Departments unsafe? Patients and professionals think so
ELSE PRESS RELEASES FROM THIS DATE:
New study explores how exposure to mix of toxic metals impacts developing kidneys
Chronic kidney disease is a growing problem worldwide and in the aging U.S. population. But could the groundwork for this progressive disease have been laid while its victims were still in utero? Newly launched research at the University of Pittsburgh School of Public Health seeks to determine if pregnant mothers’ environmental exposure to toxic metals impacts kidney development in their babies, setting the stage for a problem that doesn’t become apparent until the baby is an adult. The National Institutes of Health recently awarded a three-year, $2.2 million “high risk, high reward” grant to Dr. Alison ...
University of Cincinnati cancer experts present research at ASCO annual meeting
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Clinical Oncology (ASCO) annual meeting 2023, held in Chicago June 2-6. New trial tests immunotherapy before liver transplant Liver transplant is the best treatment for early stage liver cancer in patients with liver cirrhosis, but 25% to 35% of patients fail to reach the transplant stage due to the cancer’s progression while waiting for a transplant. UC’s Davendra Sohal, MD, will present information ...
Types of bacteria vary widely in tumors of people with early vs. late-onset colorectal cancer
WASHINGTON --- Researchers at Georgetown University’s Lombardi Comprehensive Cancer Center studied the microbiome of people with colorectal cancer and found the make-up of the bacteria, fungi and viruses in a person’s tumor varied significantly depending on whether they were diagnosed with early-onset disease (age 45 or younger) or late-onset disease (age 65 or older). These results may help answer the riddle of why more young people are developing colorectal cancer, particularly those who ...
ASCO: Luspatercept enables majority of patients with MDS to end reliance on blood transfusions
ABSTRACT: 7003 Treatment with luspatercept improved red blood cell counts and erythroid responses compared to treatment with epoetin alfa in patients with myelodysplastic syndromes (MDS), allowing the majority to no longer require regular blood transfusions. Results from the Phase III COMMANDS trial, led by researchers at The University of Texas MD Anderson Cancer Center, were reported at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. The study evaluated the efficacy and safety of first-line treatment with luspatercept, which enhances red blood cell maturation, compared with epoetin alfa, a therapy commonly used for low blood cell count, ...
ASCO23: ‘Better sexual health for female patients on endocrine therapy: Strategies across the age spectrum’
MIAMI, FLORIDA (Strictly EMBARGOED Until May 25, 2023, at 5 P.M. EDT) – Breast cancer treatments that can save a woman’s life can seriously harm her sexual health, says Dr. Kristin E. Rojas, a breast cancer surgeon at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine. Although doctors have not historically been prepared to help patients manage these toxic side effects, Rojas is leading efforts to turn the tide. Rojas, both a fellowship-trained breast surgical oncologist and a gynecologic surgeon, is a national leader in treating sexual dysfunction in female ...
ASCO23: ‘Safety & efficacy of the novel BRAF inhibitor FORE8394 in patients with advanced solid & CNS tumors’
MIAMI, FLORIDA (EMBARGOED UNTIL MAY 25, 2023, AT 5 P.M. ET) – An early-phase study led by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine along with other Cancer Centers, suggests that an experimental therapy may have promising results in treating cancers with BRAF gene alterations – including certain mutations not previously targeted by BRAF inhibitors. The Phase 1/2a study looking at safety and dosing enrolled 113 patients and targeted a wide range of cancers, including high-grade glioma, low-grade glioma, colorectal cancer, papillary thyroid cancer, melanoma, pancreatic cancer, ovarian cancer, non-small cell ...
MD Anderson Research Highlights: ASCO 2023 Special Edition
CHICAGO ― The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back. This special edition features presentations by MD Anderson researchers at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting. In addition to these studies, forthcoming press releases will highlight groundbreaking clinical research, including Phase III trial results evaluating ...
Penn Medicine at the 2023 ASCO Annual Meeting
CHICAGO – Researchers from the Abramson Cancer Center and Perelman School of Medicine at the University of Pennsylvania will present data on the latest advances in clinical cancer research at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting from June 2-6 in Chicago, Illinois. Follow us on Twitter @PennMDForum and @PennCancer for updates. Expert Interviews Experts from the Perelman School of Medicine are available to comment on a wide range of topics in cancer science and medicine during the meeting on site and by video call, telephone, or email. To arrange interviews, please contact Meagan Raeke at Meagan.Raeke@pennmedicine.upenn.edu ...
Internal job candidates have a leg up
AUSTIN, Texas – Internal job candidates have an advantage over external candidates, because they tend to work harder shortly before a hiring decision, according to new research from The University of Texas at Austin. This is true even when an internal candidate’s skills are inferior. Eric Chan, assistant professor of accounting at the McCombs School of Business, found that when a new job is on the line, employees will exert more effort to increase their chances of promotion — especially right before the decision. And managers are more likely ...
C. difficile, emerging pathogens, genomics, and antimicrobial resistance
A new study published in the peer-reviewed OMICS: A Journal of Integrative Biology identified genes for virulence and antimicrobial resistance in two bacteria that co-occur with C. difficile, suggesting these pathogens as emerging potential threats in planetary health. Click here to read the article now. Thokur Sreepathy Murali, PhD, Ankit Singh Tanwar, Padival Shruptha and colleagues from Manipal Academy of Higher Education, India, and co-author Angela Brand, MD, PhD, MPH from Maastricht University, The Netherlands, performed comparative genome analyses of three Clostridia species, ...